⚕ GalenOps CRO console
← 706 (USA)

706-1384

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 706 (USA) (Dr. Rossi) · consented 2012-09-15
Adverse events
10
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

moderate assessed 2026-08-18

Moderate ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-09-15 (study day 1.0); relationship: NONE

moderate assessed 2026-08-18

Moderate ERYTHEMA — outcome: RECOVERED/RESOLVED; onset 2012-09-15 (study day 1.0); relationship: NONE

moderate assessed 2026-08-18

Moderate ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-09-23 (study day 9.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate ERYTHEMA — outcome: RECOVERED/RESOLVED; onset 2012-09-23 (study day 9.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate EXCORIATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-09-15 (study day 1.0); relationship: NONE

moderate assessed 2026-08-18

Moderate EXCORIATION — outcome: RECOVERED/RESOLVED; onset 2012-09-15 (study day 1.0); relationship: NONE

moderate assessed 2026-08-18

Moderate PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-09-15 (study day 1.0); relationship: NONE

moderate assessed 2026-08-18

Moderate PRURITUS — outcome: RECOVERED/RESOLVED; onset 2012-09-15 (study day 1.0); relationship: NONE

moderate assessed 2026-08-18

Moderate PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-09-23 (study day 9.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate PRURITUS — outcome: RECOVERED/RESOLVED; onset 2012-09-23 (study day 9.0); relationship: PROBABLE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.